A new report from the American Cancer Society shows cancer survival rates here in the U.S. have reached a new milestone.

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

Today, the American Cancer Society (ACS) released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate ...

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

The American Cancer Society’s latest Cancer Statistics report reveals that the U.S. five-year survival rate for all cancers ...

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...